Cardiovascular risk factors associated with age-related macular degeneration: The Tromsø Study

Acta Ophthalmologica

Volumn 92, Issue 7, 2014, Pages 662-669

  Erke, Maja G ^a,b   Bertelsen, Geir ^a,b   Peto, Tunde ^c   Sjølie, Anne K ^b,d   Lindekleiv, Haakon ^b   Njølstad, Inger ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c MOORFIELDS EYE HOSPITAL   (United Kingdom)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

age related macular degeneration; body mass index; epidemiology; hypertension; physical activity; risk factors; sex difference; smoking

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

AGE RELATED MACULAR DEGENERATION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUSEN; EXERCISE; EYE PHOTOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OBESITY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; ARCTIC; CARDIOVASCULAR DISEASES; COMPLICATION; DRINKING BEHAVIOR; HYPERTENSION; MACULAR DEGENERATION; MIDDLE AGED; PROSPECTIVE STUDY; SEDENTARY LIFESTYLE; SMOKING;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ARCTIC REGIONS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MACULAR DEGENERATION; MALE; MIDDLE AGED; NORWAY; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEDENTARY LIFESTYLE; SMOKING;

EID: 84927172978     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12346     Document Type: Article

References (42)

1. Adams MK, Simpson JA, Aung KZ, et al., (2011): Abdominal obesity and age-related macular degeneration. Am J Epidemiol 173: 1246-1255.
2. Age-related Eye Disease Study Group (2000): Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-Related Eye Disease Study Report Number 3. Ophthalmology 107: 2224-2232.
3. Bertelsen G, Erke MG, von Hanno T, Mathiesen EB, Peto T, Sjolie AK, &, Njolstad I, (2013): The Tromso Eye Study: study design, methodology and results on visual acuity and refractive errors. Acta Ophthalmol 91: 635-642.
4. Bird AC, Bressler NM, Bressler SB, et al., (1995): An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
5. Bloch SB, Larsen M, &, Munch IC, (2012): Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol 153: 209-213 e202.
6. Cackett P, Wong TY, Aung T, Saw SM, Tay WT, Rochtchina E, Mitchell P, &, Wang JJ, (2008): Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. Am J Ophthalmol 146: 960-967 e961.
7. Chakravarthy U, Augood C, Bentham GC, et al., (2007): Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114: 1157-1163.
8. Chakravarthy U, Wong TY, Fletcher A, et al., (2010): Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10: 31.
9. Clemons TE, Milton RC, Klein R, Seddon JM, &, Ferris FL 3rd, (2005): Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology 112: 533-539.
10. Connell PP, Keane PA, O'Neill EC, Altaie RW, Loane E, Neelam K, Nolan JM, &, Beatty S, (2009): Risk factors for age-related maculopathy. J Ophthalmol 2009: 360764.
11. Curcio CA, (2011): Complementing apolipoprotein secretion by cultured retinal pigment epithelium. Proc Natl Acad Sci USA 108: 18569-18570.
12. Curcio CA, Johnson M, Rudolf M, &, Huang JD, (2011): The oil spill in ageing Bruch membrane. Br J Ophthalmol 95: 1638-1645.
13. Day S, Acquah K, Lee PP, Mruthyunjaya P, &, Sloan FA, (2011): Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am J Ophthalmol 152: 1014-1020.
14. Delcourt C, Michel F, Colvez A, Lacroux A, Delage M, &, Vernet MH, (2001): Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8: 237-249.
15. Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, &, Njolstad I, (2013): The sixth survey of the Tromso Study (Tromso 6) in 2007-08: collaborative research in the interface between clinical medicine and epidemiology: study objectives, design, data collection procedures, and attendance in a multipurpose population-based health survey. Scand J Public Health 41: 65-80.
16. Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H, &, Njolstad I, (2012): Prevalence of age-related macular degeneration in elderly Caucasians: the Tromso Eye Study. Ophthalmology 119: 1737-1743.
17. Erke MG, Bertelsen G, Peto T, Sjolie AK, Lindekleiv H, &, Njolstad I, (2013): Lactation, female hormones and age-related macular degeneration: the Tromso Study. Br J Ophthalmol 97: 1036-1039.
18. Gulsvik AK, Thelle DS, Samuelsen SO, Myrstad M, Mowe M, &, Wyller TB, (2012): Ageing, physical activity and mortality-a 42-year follow-up study. Int J Epidemiol 41: 521-530.
19. Hu CC, Ho JD, &, Lin HC, (2010): Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study. Stroke 41: 613-617.
20. Hyman L, Schachat AP, He Q, &, Leske MC, (2000): Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 118: 351-358.
21. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, &, Njolstad I, (2012): Cohort profile: the Tromso Study. Int J Epidemiol 41: 961-967.
22. Kishan AU, Modjtahedi BS, Martins EN, Modjtahedi SP, &, Morse LS, (2011): Lipids and age-related macular degeneration. Surv Ophthalmol 56: 195-213.
23. Klein R, Klein BE, Tomany SC, &, Cruickshanks KJ, (2003): The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Ophthalmology 110: 636-643.
24. Klein R, Deng Y, Klein BE, et al., (2007): Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 143: 473-483.
25. Knudtson MD, Klein R, &, Klein BE, (2006): Physical activity and the 15-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Br J Ophthalmol 90: 1461-1463.
26. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, &, de Jong PT, (2003): Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44: 3771-3777.
27. Lindekleiv H, &, Erke MG, (2013): Projected prevalence of age-related macular degeneration in Scandinavia 2012-2040. Acta Ophthalmol 91: 307-311.
28. Mares JA, Voland RP, Sondel SA, et al., (2011): Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol 129: 470-480.
29. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, &, Taylor HR, (2001): Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119: 1455-1462.
30. Metelitsina TI, Grunwald JE, DuPont JC, &, Ying GS, (2006): Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol 90: 342-346.
31. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, &, Mariotti SP, (2004): Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
32. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, &, Owen CG, (2012): Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119: 571-580.
33. Schaumberg DA, Christen WG, Hankinson SE, &, Glynn RJ, (2001): Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol 119: 1259-1265.
34. Seddon JM, Cote J, Davis N, &, Rosner B, (2003): Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121: 785-792.
35. Smith W, Mitchell P, Leeder SR, &, Wang JJ, (1998): Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 116: 583-587.
36. Smith W, Assink J, Klein R, et al., (2001): Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108: 697-704.
37. Tan JS, Wang JJ, Liew G, Rochtchina E, &, Mitchell P, (2008): Age-related macular degeneration and mortality from cardiovascular disease or stroke. Br J Ophthalmol 92: 509-512.
38. Thijssen DH, Cable NT, &, Green DJ, (2012): Impact of exercise training on arterial wall thickness in humans. Clin Sci (Lond) 122: 311-322.
39. Tomany SC, Wang JJ, Van Leeuwen R, et al., (2004): Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 111: 1280-1287.
40. Vitale C, Mendelsohn ME, &, Rosano GM, (2009): Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6: 532-542.
41. Wieberdink RG, Ho L, Ikram MK, Koudstaal PJ, Hofman A, de Jong PT, Vingerling JR, &, Breteler MM, (2011): Age-related macular degeneration and the risk of stroke: the Rotterdam study. Stroke 42: 2138-2142.
42. Xu W, Grunwald JE, Metelitsina TI, DuPont JC, Ying GS, Martin ER, Dunaief JL, &, Brucker AJ, (2010): Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol 150: 40-47 e42.